$0.13
-0.00 (-2.01%)
Market Cap
$868K
Shares Outstanding
4,341,956
Institutional Holders
4
Total Inst. Value
$57K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
New Positions
3
Closed Positions
6
Increased
0
Decreased
1
Institutional Ownership Trend
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | UBS Group AG | $26K | 22,425 |
| 2 | TWO SIGMA SECURITIES, LLCNew | $16K | 13,627 |
| 3 | CITADEL ADVISORS LLCNew | $15K | 13,539 |
| 4 | HRT FINANCIAL LPNew | $15 | 13,507 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| TWO SIGMA SECURITIES, LLCNew | +14K | $16K |
| CITADEL ADVISORS LLCNew | +14K | $15K |
| HRT FINANCIAL LPNew | +14K | $15 |
Top Sellers
| Fund | Shares Removed | Value |
|---|---|---|
| UBS Group AG | -15K | $26K |
Related Stocks
Frequently Asked Questions
How many institutional investors hold VRAX?
As of Q1 2025, 4 institutional investors report holding VRAX (Virax Biolabs Group Limited) in their 13F filings.
Which hedge fund owns the most VRAX?
The largest institutional holder of VRAX is UBS Group AG with $26K in shares.
Are institutions buying or selling VRAX?
This quarter, 3 institutions opened new positions in VRAX and 6 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.